Conférences - Législation en médecine et pharmacologie

Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.

Tél.: [+410 501 5777];     Email.: pkumar@fdamap.com

20th Pharmacovigilance 2019 Conference provides the strongest context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies that cannot be found in any other meeting. The content of this event is developed by top experts from the biopharmaceutical industry and global regulatory agencies, and Virtue Insight will convene the best speakers from around the world to discuss the current challenges and issues that matter most to professionals working in the field.

Tél.: [+91 44 24762472];     Email.: kavitha@virtueinsight.co.in

Pharmacovigilance, DrugSafety, ProductSafety, DrugDevelopment, ClinicalSafety, patientsafety, RiskManagement, regulatoryaffairs

Regulatory professionals have to write highly technical documents for a variety of audience. These documents include reports, protocols, clinical trial and marketing approval applications, technical reports on studies, and communication documents. This workshop will address best practices, and regulatory strategies on how to write effective documents covering anywhere from simple issues such as minutes of meetings and correspondence notes, to highly sophisticated nonclinical and clinical study reports, and regulatory submissions to FDA, EMA, Health Canada, and other regulators.

Tél.: [+410 501 5777];     Email.: pkumar@fdamap.com

Virtue Insight

14th Biosimilars Congregation 2019 will be your opportunity with leading industry experts to discuss from development, manufacturing to commercialization - The current landscape, legal, regulatory, funding, challenges, market access strategy, business models and how to get to market.

Tél.: [+91 44 24762472];     Email.: kavitha@virtueinsight.co.in

Biopharmaceuticals, Biotherapeutics, Follow on Biologics, Follow on Proteins, Biologics, Biotechnology, Biogenerics, Legal Affairs, Intellectual Property

INM - Leibniz Institute for New Materials

A new paradigm in material synthesis is emerging, in which living cells are used as active components in man-made materials to augment non-living matter with life-like capabilities. “Living Materials” promise to change the way we design technological and medical devices, and open infinite possibilities for programmable functions. Self-ventilating sportswear, bio-syncretic robots, self-renewing bioremediation devices, biosensing tattoos, personalized drug delivery systems or self-healing concrete walls are just a few examples. This conference will provide an open forum for sharing recent advances and discussing current challenges and potential of Living Materials among experts and newcomers in the field. It will gather leading scientists and industrial partners, and tackle fundamental science and application-oriented approaches.

Conference office;     Email.: livmat2020@leibniz-inm.de

living materials, controlled drug delivery, active implants, medical materials, living therapeutics,

Biotechnologie,    Produits chimiques et science des matériaux

SMi Group

SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field. For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Organ-on-chips, microfluidics, cell culture, 3D cell culture, 3D bioprinting, bioprinting, organoid, extracellular matrix, ECM, tissue engineering, physiochemical factors, cell-based assay, cytotoxicity, cell metabolic pathways, cancer research, molecular diagnostics, cell and gene therapy, microphysiological, co-culture systems complex in-vitro models, high throughput screening, 3D imaging, drug screening, extracellular matrix scaffolds, 3D drug development, regenerative therapies

Pharmacologie et développement des médicaments,    Cellules souches

The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores.Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security.We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.

Tél.: [02070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecuritySerialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Research Lake International

2020 International Conference and Exhibition on Traditional & Alternative Medicine during March 26-27 2020, Madrid, Spain. Traditional Medicine 2020 aims to gather leading traditional physicians’ educational scientists, researchers and research students to exchange & share their experiences and research results about all aspects of Traditional and Alternative medicine. Traditional Medicine 2020 includes prompt keynote presentations, oral talks, poster presentations and exhibitions, workshop, Symposium. We gladly welcome attendees from all around the world to present their ideas, expand their networks, knowledge, and recent innovations and inventions in the field of Traditional & Alternative Medicine.

Tél.: [+1 (647) 551-8989];     Email.: kate.john.0295@gmail.com

Medicine Conference Topics: Traditional, Alternative, Herbal, Ayurveda, Chinese, Japanese, Arabic, Unani, Homeopathic, Pharmacognosy and medicine for cancer.

Médecine (en général),    Médecine traditionnelle et médecine non conventionnelle

This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Therapeutic gene editing, Extrahepatic delivery of nucleic acids, Characterization of therapeutic nanoparticles and control strategies for manufacturing, New linkers for triggered or controlled release, New long acting technologies, Tumor targeting with nanoparticles, recent progress and challenges

Pharmacologie et développement des médicaments,    Pharmacogénétique, Médecine personnalisée